Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma Manohan SinnaduraiKerrie L. McDonald Topic Review 14 March 2017 Pages: 359 - 372
N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis Diamanto LazariGeorge A. AlexiouAthanasios P. Kyritsis Laboratory Investigation 01 April 2017 Pages: 373 - 381
Serum amyloid A1 is upregulated in human glioblastoma Franciele Hinterholz KnebelMiyuki UnoAna Campa Laboratory Investigation 11 March 2017 Pages: 383 - 391
Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition Pingde ZhangStella SunGilberto Ka Kit Leung Laboratory Investigation 14 March 2017 Pages: 393 - 400
Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model James C. League-PascualCynthia M. Lester-McCullyKatherine E. Warren Laboratory Investigation 13 March 2017 Pages: 401 - 407
Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma Huajie LiuBin LiuQi Pang Laboratory Investigation 21 March 2017 Pages: 409 - 417
Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution M. AzoulayF. SantosBassam S. Abdulkarim Clinical Study 03 April 2017 Pages: 419 - 426
Choroid plexus tumors in adult and pediatric populations: the Cleveland Clinic and University Hospitals experience Michal BaharHasan HashemJohannes Wolff Clinical Study 13 March 2017 Pages: 427 - 432
Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan Patrizia FarinaEmeline TabouretOlivier Chinot Clinical Study 06 March 2017 Pages: 433 - 437
Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome Zachary A. CorbinAnnie Nguyen-LinSeema Nagpal Clinical Study 07 March 2017 Pages: 439 - 446
The effect of socioeconomic status on gross total resection, radiation therapy and overall survival in patients with gliomas Sayantan DebArjun Vivek PendharkarAtman Desai Clinical Study 03 March 2017 Pages: 447 - 453
Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases Giuseppe MinnitiSergio PaoliniMattia Osti Clinical Study 04 March 2017 Pages: 455 - 462
Neutrophil–lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival Matthew MasonCatherine MauriceCaroline Chung Clinical Study 22 March 2017 Pages: 463 - 471
Clival paragangliomas: a report of two cases involving the midline skull base and review of the literature Jacob RuzevickEun Kyung KohManuel Ferreira Clinical Study 16 March 2017 Pages: 473 - 478
Comparing available criteria for measuring brain metastasis response to immunotherapy Jack M. QianAmit MahajanVeronica L. S. Chiang Clinical Study 08 March 2017 Pages: 479 - 485
Chordoid glioma of the third ventricle: report of a rapidly progressive case Amalie A. ErwoodJose E. Velazquez-VegaDaniel J. Brat Clinical Study 18 March 2017 Pages: 487 - 495
Demographics, patterns of care, and survival in pediatric medulloblastoma Emily V. DresslerTherese A. DolecekJohn L. Villano Clinical Study 13 March 2017 Pages: 497 - 506
Incidence of CNS tumors in Appalachian children Bin HuangAlice LuoJohn L. Villano Clinical Study 11 March 2017 Pages: 507 - 512
The effect of regadenoson on the integrity of the human blood–brain barrier, a pilot study Sadhana JacksonRichard T. GeorgeStuart A. Grossman Clinical Study 17 March 2017 Pages: 513 - 519
Glioblastoma recurrence, progression, and dissemination as a purely subdural gliosarcoma R. Michael MeyerCharles A. MillerMichael S. Dirks Letter to the Editor 13 March 2017 Pages: 521 - 522
Tumor types, breast tumor subtypes and extension of systemic disease may influence outcome in cancer patients with brain metastases Kadri Altundag Letter to the Editor 02 March 2017 Pages: 523 - 523
Radio-sensitising effect of T-DM1 should not be discarded for the efficacy of radiosurgery in the management of brain metastases in patients with HER2-positive metastatic breast cancer Kadri Altundag Letter to the Editor 23 March 2017 Pages: 525 - 525